Amputation of patients with diabetic foot is a major issue worldwide, particularly from a medical and economic standpoint. This meta-analysis aimed to identify significant risk factors of high amputation rate among epidemiologic and patient behavior–related predictors in diabetic patients. A systematic literature review and meta-analysis were performed using MEDLINE, EMBASE, and Cochrane databases. Seven variables were extracted from the included studies and evaluated based on amputation rate. The Newcastle-Ottawa scale was used to assess the quality of the studies. The search strategy identified 101 publications. After screening, 33 articles were selected for review. Male sex and smoking were identified as significant risk factors of high amputation rate of diabetic foot. Although further investigation of long-term and randomized controlled studies is needed, we identified 2 variables as significant risk factors for high amputation rate in diabetic patients in this meta-analysis.
WildSRoglicGGreenASicreeRKingH. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care. 2004;27:1047-1053.
2.
BeaneyAJNunneyIGoodayCDhatariyaK. Factors determining the risk of diabetes foot amputations—a retrospective analysis of a tertiary diabetes foot care service. Diabetes Res Clin Pract. 2016;114:69-74.
3.
Martins-MendesDMonteiro-SoaresMBoykoEJ. The independent contribution of diabetic foot ulcer on lower extremity amputation and mortality risk. J Diabetes Complications. 2014;28:632-638.
4.
ViswanathanVWadudJRMadhavanS. Comparison of post amputation outcome in patients with type 2 diabetes from specialized foot care centres in three developing countries. Diabetes Res Clin Pract. 2010;88:146-150.
5.
IzumiYSatterfieldKLeeSHarklessLBLaveryLA. Mortality of first-time amputees in diabetics: a 10-year observation. Diabetes Res Clin Pract. 2009;83:126-131.
6.
BoultonAJVileikyteLRagnarson-TennvallGApelqvistJ. The global burden of diabetic foot disease. Lancet. 2005;366:1719-1724.
7.
ApelqvistJBakkerKvan HoutumWHNabuurs-FranssenMHSchaperNC. International consensus and practical guidelines on the management and the prevention of the diabetic foot. International Working Group on the Diabetic Foot. Diabetes Metab Res Rev. 2000;16(suppl 1):S84-S92.
8.
AdlerAIErqouSLimaTARobinsonAH. Association between glycated haemoglobin and the risk of lower extremity amputation in patients with diabetes mellitus—review and meta-analysis. Diabetologia. 2010;53:840-849.
9.
MorbachSFurchertHGroblinghoffU. Long-term prognosis of diabetic foot patients and their limbs: amputation and death over the course of a decade. Diabetes Care. 2012;35:2021-2027.
10.
LeeKMKimWHLeeJHChoiMS. Risk factors of treatment failure in diabetic foot ulcer patients. Arch Plast Surg. 2013;40:123-128.
11.
TangZQChenHLZhaoFF. Gender differences of lower extremity amputation risk in patients with diabetic foot: a meta-analysis. Int J Low Extrem Wounds. 2014;13:197-204.
12.
ZhouZYLiuYKChenHLYangHLLiuF. HbA1c and lower extremity amputation risk in patients with diabetes: a meta-analysis. Int J Low Extrem Wounds. 2015;14:168-177.
13.
LiberatiAAltmanDGTetzlaffJ. The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration. J Clin Epidemiol. 2009;62:e1-e34.
14.
StangA. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25:603-605.
15.
DeeksJJDinnesJD’AmicoR. Evaluating non-randomised intervention studies. Health Technol Assess. 2003;7:1-173.
16.
HigginsJPThompsonSG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21:1539-1558.
17.
ParisiMCMoura NetoAMenezesFH. Baseline characteristics and risk factors for ulcer, amputation and severe neuropathy in diabetic foot at risk: the BRAZUPA study. Diabetol Metab Syndr. 2016;8:25.
18.
JiangYRanXJiaL. Epidemiology of type 2 diabetic foot problems and predictive factors for amputation in China. Int J Low Extrem Wounds. 2015;14:19-27.
19.
BruunCGuassoraADNielsenABSiersmaVHolsteinPEde Fine OlivariusN. Motivation, effort and life circumstances as predictors of foot ulcers and amputations in people with type 2 diabetes mellitus. Diabet Med. 2014;31:1468-1476.
20.
QuiliciMTDel Fiol FdeSVieiraAEToledoMI. Risk factors for foot amputation in patients hospitalized for diabetic foot infection. J Diabetes Res. 2016;2016:8931508.
21.
PickwellKSiersmaVKarsM. Predictors of lower-extremity amputation in patients with an infected diabetic foot ulcer. Diabetes Care. 2015;38:852-857.
22.
LiXXiaoTWangY. Incidence, risk factors for amputation among patients with diabetic foot ulcer in a Chinese tertiary hospital. Diabetes Res Clin Pract. 2011;93:26-30.
23.
Moura NetoAZantut-WittmannDEFernandesTDNeryMParisiMC. Risk factors for ulceration and amputation in diabetic foot: study in a cohort of 496 patients. Endocrine. 2013;44:119-124.
24.
SunJHTsaiJSHuangCH. Risk factors for lower extremity amputation in diabetic foot disease categorized by Wagner classification. Diabetes Res Clin Pract. 2012;95:358-363.
25.
LipskyBAWeigeltJASunXJohannesRSDerbyKGTabakYP. Developing and validating a risk score for lower-extremity amputation in patients hospitalized for a diabetic foot infection. Diabetes Care. 2011;34:1695-1700.
26.
KarakasAArslanECakmakTAydinIAkgulEODemirbasS. Predictive value of soluble CD14, interleukin-6 and procalcitonin for lower extremity amputation in people with diabetes with foot ulcers: a pilot study. Pak J Med Sci. 2014;30:578-582.
27.
AydinKIsildakMKarakayaJGurlekA. Change in amputation predictors in diabetic foot disease: effect of multidisciplinary approach. Endocrine. 2010;38:87-92.
28.
TaburSErenMAÇelikY. The major predictors of amputation and length of stay in diabetic patients with acute foot ulceration. Wien Klin Wochenschr. 2015;127:45-50.
29.
ZubairMMalikAAhmadJ. Plasma adiponectin, IL-6, hsCRP, and TNF-alpha levels in subject with diabetic foot and their correlation with clinical variables in a North Indian tertiary care hospital. Indian J Endocrinol Metab. 2012;16:769-776.
30.
WattsSADalyBAnthonyMMcDonaldPKhouryADaharW. The effect of age, gender, risk level and glycosylated hemoglobin in predicting foot amputation in HMO patients with diabetes. J Am Acad Nurse Pract. 2001;13:230-235.
31.
LacleAValero-JuanLF. Diabetes-related lower-extremity amputation incidence and risk factors: a prospective seven-year study in Costa Rica. Rev Panam Salud Publica. 2012;32:192-198.
32.
GershaterMALondahlMNybergP. Complexity of factors related to outcome of neuropathic and neuroischaemic/ischaemic diabetic foot ulcers: a cohort study. Diabetologia. 2009;52:398-407.
33.
AdlerAIBoykoEJAhroniJHSmithDG. Lower-extremity amputation in diabetes. The independent effects of peripheral vascular disease, sensory neuropathy, and foot ulcers. Diabetes Care. 1999;22:1029-1035.
34.
Al-RubeaanKAl DerwishMOuiziS. Diabetic foot complications and their risk factors from a large retrospective cohort study. PLoS One. 2015;10:e0124446.
35.
LaiYJHuHYLinCHLeeSTKuoSCChouP. Incidence and risk factors of lower extremity amputations in people with type 2 diabetes in Taiwan, 2001-2010. J Diabetes. 2015;7:260-267.
36.
McEwenLNYlitaloKRHermanWHWrobelJS. Prevalence and risk factors for diabetes-related foot complications in Translating Research Into Action for Diabetes (TRIAD). J Diabetes Complications. 2013;27:588-592.
37.
GoldbergJBGoodneyPPCronenwettJLBakerF. The effect of risk and race on lower extremity amputations among Medicare diabetic patients. J Vasc Surg. 2012;56:1663-1668.
38.
ShojaiefardAKhorgamiZLarijaniB. Independent risk factors for amputation in diabetic foot. Int J Diabetes Dev Ctries. 2008;28:32-37.
39.
MarkowitzJSGuttermanEMMageeGMargolisDJ. Risk of amputation in patients with diabetic foot ulcers: a claims-based study. Wound Repair Regen. 2006;14:11-17.
40.
TsengCH. Prevalence of lower-extremity amputation among patients with diabetes mellitus: is height a factor?CMAJ. 2006;174:319-323.
41.
MiyajimaSShiraiAYamamotoSOkadaNMatsushitaT. Risk factors for major limb amputations in diabetic foot gangrene patients. Diabetes Res Clin Pract. 2006;71:272-279.
42.
HamalainenHRonnemaaTHalonenJPToikkaT. Factors predicting lower extremity amputations in patients with type 1 or type 2 diabetes mellitus: a population-based 7-year follow-up study. J Intern Med. 1999;246:97-103.
43.
LehtoSRonnemaaTPyoralaKLaaksoM. Risk factors predicting lower extremity amputations in patients with NIDDM. Diabetes Care. 1996;19:607-612.
44.
ApelqvistJLarssonJAgardhCD. Long-term prognosis for diabetic patients with foot ulcers. J Intern Med. 1993;233:485-491.
45.
AkinciBYenerSYesilSYaparNKucukyavasYBayraktarF. Acute phase reactants predict the risk of amputation in diabetic foot infection. J Am Podiatr Med Assoc. 2011;101:1-6.
46.
AkanjiAOFamuyiwaOOAdetuyibiA. Factors influencing the outcome of treatment of foot lesions in Nigerian patients with diabetes mellitus. Q J Med. 1989;73:1005-1014.
47.
HumphreyARDowseGKThomaKZimmetPZ. Diabetes and nontraumatic lower extremity amputations. Incidence, risk factors, and prevention—a 12-year follow-up study in Nauru. Diabetes Care. 1996;19:710-714.
48.
SmithDGAssalMReiberGEVathCLeMasterJWallaceC. Minor environmental trauma and lower extremity amputation in high-risk patients with diabetes: incidence, pivotal events, etiology, and amputation level in a prospectively followed cohort. Foot Ankle Int. 2003;24:690-695.
49.
MossSEKleinRKleinBE. The prevalence and incidence of lower extremity amputation in a diabetic population. Arch Intern Med. 1992;152:610-616.
50.
NelsonRGGohdesDMEverhartJE. Lower-extremity amputations in NIDDM. 12-yr follow-up study in Pima Indians. Diabetes Care. 1988;11:8-16.
51.
SelbyJVZhangD. Risk factors for lower extremity amputation in persons with diabetes. Diabetes Care. 1995;18:509-516.
52.
TivestenAMellstromDJutbergerH. Low serum testosterone and high serum estradiol associate with lower extremity peripheral arterial disease in elderly men. The MrOS Study in Sweden. J Am Coll Cardiol. 2007;50:1070-1076.
53.
GordonPFlanaganP. Smoking: a risk factor for vascular disease. J Vasc Nurs. 2016;34:79-86.
54.
HowardGWagenknechtLEBurkeGL. Cigarette smoking and progression of atherosclerosis: the Atherosclerosis Risk in Communities (ARIC) Study. JAMA. 1998;279:119-124.
55.
WatersDLespéranceJGladstoneP. Effects of cigarette smoking on the angiographic evolution of coronary atherosclerosis. A Canadian Coronary Atherosclerosis Intervention Trial (CCAIT) Substudy. CCAIT Study Group. Circulation. 1996;94:614-621.
56.
BaltaciDAydinLYAlasanF. Evaluation of smoking cessation practice by physicians for hospitalized patients in a tertiary hospital. J Pak Med Assoc. 2016;66:1547-1553.
57.
SiddiquiFHuqueRDogarO. Updated evidence-based guide to smoking cessation therapies. Br J Community Nurs. 2016;21:607-611.
58.
BeckertSWitteMWickeCKonigsrainerACoerperS. A new wound-based severity score for diabetic foot ulcers: a prospective analysis of 1,000 patients. Diabetes Care. 2006;29:988-992.
59.
BoykoEJAhroniJHCohenVNelsonKMHeagertyPJ. Prediction of diabetic foot ulcer occurrence using commonly available clinical information: the Seattle Diabetic Foot Study. Diabetes Care. 2006;29:1202-1207.
60.
FortingtonLVRommersGMGeertzenJHPostemaKDijkstraPU. Mobility in elderly people with a lower limb amputation: a systematic review. J Am Med Dir Assoc. 2012;13:319-325.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
